SUNPHARMA.NS vs. HINDUNILVR.NS
Compare and contrast key facts about Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) and Hindustan Unilever Limited (HINDUNILVR.NS).
Performance
SUNPHARMA.NS vs. HINDUNILVR.NS - Performance Comparison
Loading graphics...
SUNPHARMA.NS vs. HINDUNILVR.NS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SUNPHARMA.NS Sun Pharmaceutical Industries Limited | 1.16% | -7.98% | 51.11% | 27.16% | 19.74% | 44.40% | 38.20% | 1.13% | -24.40% | -8.73% |
HINDUNILVR.NS Hindustan Unilever Limited | -10.85% | 2.61% | -10.79% | 5.64% | 10.20% | -0.15% | 26.77% | 7.00% | 34.80% | 68.10% |
Returns By Period
In the year-to-date period, SUNPHARMA.NS achieves a 1.16% return, which is significantly higher than HINDUNILVR.NS's -10.85% return. Over the past 10 years, SUNPHARMA.NS has underperformed HINDUNILVR.NS with an annualized return of 8.72%, while HINDUNILVR.NS has yielded a comparatively higher 10.97% annualized return.
SUNPHARMA.NS
- 1D
- -1.63%
- 1M
- -1.37%
- YTD
- 1.16%
- 6M
- 6.33%
- 1Y
- 2.77%
- 3Y*
- 21.83%
- 5Y*
- 24.35%
- 10Y*
- 8.72%
HINDUNILVR.NS
- 1D
- 0.46%
- 1M
- -11.03%
- YTD
- -10.85%
- 6M
- -16.95%
- 1Y
- -4.71%
- 3Y*
- -4.82%
- 5Y*
- -1.08%
- 10Y*
- 10.97%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SUNPHARMA.NS vs. HINDUNILVR.NS — Risk / Return Rank
SUNPHARMA.NS
HINDUNILVR.NS
SUNPHARMA.NS vs. HINDUNILVR.NS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) and Hindustan Unilever Limited (HINDUNILVR.NS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SUNPHARMA.NS | HINDUNILVR.NS | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.15 | -0.25 | +0.40 |
Sortino ratioReturn per unit of downside risk | 0.33 | -0.23 | +0.56 |
Omega ratioGain probability vs. loss probability | 1.04 | 0.97 | +0.07 |
Calmar ratioReturn relative to maximum drawdown | 0.05 | -0.23 | +0.29 |
Martin ratioReturn relative to average drawdown | 0.10 | -0.60 | +0.71 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| SUNPHARMA.NS | HINDUNILVR.NS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.15 | -0.25 | +0.40 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.21 | -0.06 | +1.26 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.32 | 0.52 | -0.19 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.74 | 0.46 | +0.29 |
Correlation
The correlation between SUNPHARMA.NS and HINDUNILVR.NS is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
SUNPHARMA.NS vs. HINDUNILVR.NS - Dividend Comparison
SUNPHARMA.NS's dividend yield for the trailing twelve months is around 0.95%, less than HINDUNILVR.NS's 3.53% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SUNPHARMA.NS Sun Pharmaceutical Industries Limited | 0.95% | 0.93% | 0.72% | 0.91% | 1.00% | 0.89% | 0.68% | 0.64% | 0.46% | 0.61% | 0.16% | 0.37% |
HINDUNILVR.NS Hindustan Unilever Limited | 3.53% | 3.14% | 2.28% | 1.50% | 1.41% | 1.36% | 1.57% | 1.25% | 1.15% | 1.32% | 2.00% | 0.75% |
Drawdowns
SUNPHARMA.NS vs. HINDUNILVR.NS - Drawdown Comparison
The maximum SUNPHARMA.NS drawdown since its inception was -71.46%, which is greater than HINDUNILVR.NS's maximum drawdown of -66.21%. Use the drawdown chart below to compare losses from any high point for SUNPHARMA.NS and HINDUNILVR.NS.
Loading graphics...
Drawdown Indicators
| SUNPHARMA.NS | HINDUNILVR.NS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -71.46% | -66.21% | -5.25% |
Max Drawdown (1Y)Largest decline over 1 year | -14.83% | -22.24% | +7.41% |
Max Drawdown (5Y)Largest decline over 5 years | -19.13% | -30.46% | +11.33% |
Max Drawdown (10Y)Largest decline over 10 years | -60.80% | -30.46% | -30.34% |
Current DrawdownCurrent decline from peak | -9.89% | -28.90% | +19.01% |
Average DrawdownAverage peak-to-trough decline | -21.03% | -17.63% | -3.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.96% | 8.57% | -0.61% |
Volatility
SUNPHARMA.NS vs. HINDUNILVR.NS - Volatility Comparison
Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) and Hindustan Unilever Limited (HINDUNILVR.NS) have volatilities of 6.32% and 6.37%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| SUNPHARMA.NS | HINDUNILVR.NS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.32% | 6.37% | -0.05% |
Volatility (6M)Calculated over the trailing 6-month period | 12.66% | 13.31% | -0.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.39% | 18.85% | +0.54% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.54% | 19.91% | +0.63% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.40% | 21.72% | +5.68% |
Financials
SUNPHARMA.NS vs. HINDUNILVR.NS - Financials Comparison
This section allows you to compare key financial metrics between Sun Pharmaceutical Industries Limited and Hindustan Unilever Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities